Tags

Type your tag names separated by a space and hit enter

Multiple endocrine neoplasia type 1.
Front Horm Res. 2013; 41:1-15.FH

Abstract

Multiple endocrine neoplasia type 1 (MEN1) is an autosomal-dominant tumor syndrome characterized by the occurrence of tumors in multiple endocrine tissues and nonendocrine tissues. The three main endocrine tissues most frequently affected by tumors are parathyroid (95%), enteropancreatic neuroendocrine (50%) and anterior pituitary (40%). Tumors are caused by a heterozygous germline-inactivating mutation in the MEN1 gene (1st hit) followed by somatic inactivating mutation or loss of the normal copy of the gene (2nd hit), leading to complete loss of function of the encoded protein menin. Most of the disease features and tumors are recapitulated in mouse models with heterozygous germline loss of the Men1 gene. Also, tissue-specific tumors are observed in mouse models with homozygous somatic loss of the Men1 gene specifically in MEN1-associated endocrine tissues. Hence, mouse models could serve as possible surrogates for studying MEN1 and related states. To gain insights into MEN1 pathophysiology, menin-interacting partners and pathways have been identified to investigate its tumor suppressor and other functions. Also, the 3D crystal structure of menin has been deciphered which could be useful to reveal the relevance of MEN1 gene mutations and menin's interactions. This chapter covers clinical, genetic and basic findings about the MEN1 syndrome, MEN1 gene and its product protein menin.

Authors+Show Affiliations

Metabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, MD 20892, USA. SunitaA @ mail.nih.gov

Pub Type(s)

Journal Article
Research Support, N.I.H., Intramural
Review

Language

eng

PubMed ID

23652667

Citation

Agarwal, Sunita K.. "Multiple Endocrine Neoplasia Type 1." Frontiers of Hormone Research, vol. 41, 2013, pp. 1-15.
Agarwal SK. Multiple endocrine neoplasia type 1. Front Horm Res. 2013;41:1-15.
Agarwal, S. K. (2013). Multiple endocrine neoplasia type 1. Frontiers of Hormone Research, 41, 1-15. https://doi.org/10.1159/000345666
Agarwal SK. Multiple Endocrine Neoplasia Type 1. Front Horm Res. 2013;41:1-15. PubMed PMID: 23652667.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Multiple endocrine neoplasia type 1. A1 - Agarwal,Sunita K, Y1 - 2013/03/19/ PY - 2013/5/9/entrez PY - 2013/5/9/pubmed PY - 2013/12/18/medline SP - 1 EP - 15 JF - Frontiers of hormone research JO - Front Horm Res VL - 41 N2 - Multiple endocrine neoplasia type 1 (MEN1) is an autosomal-dominant tumor syndrome characterized by the occurrence of tumors in multiple endocrine tissues and nonendocrine tissues. The three main endocrine tissues most frequently affected by tumors are parathyroid (95%), enteropancreatic neuroendocrine (50%) and anterior pituitary (40%). Tumors are caused by a heterozygous germline-inactivating mutation in the MEN1 gene (1st hit) followed by somatic inactivating mutation or loss of the normal copy of the gene (2nd hit), leading to complete loss of function of the encoded protein menin. Most of the disease features and tumors are recapitulated in mouse models with heterozygous germline loss of the Men1 gene. Also, tissue-specific tumors are observed in mouse models with homozygous somatic loss of the Men1 gene specifically in MEN1-associated endocrine tissues. Hence, mouse models could serve as possible surrogates for studying MEN1 and related states. To gain insights into MEN1 pathophysiology, menin-interacting partners and pathways have been identified to investigate its tumor suppressor and other functions. Also, the 3D crystal structure of menin has been deciphered which could be useful to reveal the relevance of MEN1 gene mutations and menin's interactions. This chapter covers clinical, genetic and basic findings about the MEN1 syndrome, MEN1 gene and its product protein menin. SN - 1662-3762 UR - https://www.unboundmedicine.com/medline/citation/23652667/Multiple_endocrine_neoplasia_type_1_ L2 - https://www.karger.com?DOI=10.1159/000345666 DB - PRIME DP - Unbound Medicine ER -